NASDAQ:CBDC - Apotheca Biosciences Stock Price, News, & Analysis

$0.04
-0.01 (-22.22 %)
(As of 07/18/2019 03:19 AM ET)
Today's Range
$0.03
Now: $0.0350
$0.0350
50-Day Range
$0.0275
MA: $0.05
$0.0851
52-Week Range
$0.0250
Now: $0.0350
$0.74
Volume4,100 shs
Average Volume81,166 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Apotheca Biosciences, Inc. develops cutting-edge medical products, nutraceuticals, formulation, and delivery technologies for the healthcare and consumer care industry. The company is based in the United States.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:CBDC
CUSIPN/A
CIKN/A
WebN/A
Phone727-228-3994

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CBDC News and Ratings via Email

Sign-up to receive the latest news and ratings for CBDC and its competitors with MarketBeat's FREE daily newsletter.

Apotheca Biosciences (NASDAQ:CBDC) Frequently Asked Questions

What is Apotheca Biosciences' stock symbol?

Apotheca Biosciences trades on the NASDAQ under the ticker symbol "CBDC."

Has Apotheca Biosciences been receiving favorable news coverage?

Press coverage about CBDC stock has trended neutral on Thursday, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Apotheca Biosciences earned a media sentiment score of 0.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Apotheca Biosciences.

Who are some of Apotheca Biosciences' key competitors?

What other stocks do shareholders of Apotheca Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apotheca Biosciences investors own include Energy Recovery (ERII), Dropbox (DBX), Cyberark Software (CYBR), Cisco Systems (CSCO), Cronos Group (CRON), Computer Programs & Systems (CPSI), Alpha and Omega Semiconductor (AOSL), Amarin (AMRN), Advanced Micro Devices (AMD) and Analog Devices (ADI).

Who are Apotheca Biosciences' key executives?

Apotheca Biosciences' management team includes the folowing people:
  • Dr. P. C. Sundareswaran, Chairman, CEO & CFO
  • Ms. Deirdre Fernandes, COO & Director
  • Mr. John Verghese, CTO & Director (Age 58)
  • Mr. Craig Huffman, Legal Council
  • Karin Rohret, Sec.

How do I buy shares of Apotheca Biosciences?

Shares of CBDC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Apotheca Biosciences' stock price today?

One share of CBDC stock can currently be purchased for approximately $0.0350.

How can I contact Apotheca Biosciences?

The company can be reached via phone at 727-228-3994.


MarketBeat Community Rating for Apotheca Biosciences (NASDAQ CBDC)

Community Ranking:  2.1 out of 5 (star star)
Outperform Votes:  10 (Vote Outperform)
Underperform Votes:  14 (Vote Underperform)
Total Votes:  24
MarketBeat's community ratings are surveys of what our community members think about Apotheca Biosciences and other stocks. Vote "Outperform" if you believe CBDC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CBDC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2019 by MarketBeat.com Staff

Featured Article: What is a short straddle?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel